108 related articles for article (PubMed ID: 10493930)
1. Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway.
Falnes PO; Welker R; Kräusslich HG; Olsnes S
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):199-207. PubMed ID: 10493930
[TBL] [Abstract][Full Text] [Related]
2. Design of toxins that can be activated by cell-specific proteases and their potential use in targeted cell killing.
Falnes PO
Int J Med Microbiol; 2000 Oct; 290(4-5):471-6. PubMed ID: 11111928
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway.
Falnes PO; Olsnes S
EMBO J; 1998 Jan; 17(2):615-25. PubMed ID: 9430652
[TBL] [Abstract][Full Text] [Related]
4. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases.
Blumenzweig I; Baraz L; Friedler A; Danielson UH; Gilon C; Steinitz M; Kotler M
Biochem Biophys Res Commun; 2002 Apr; 292(4):832-40. PubMed ID: 11944889
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease.
Hutoran M; Britan E; Baraz L; Blumenzweig I; Steinitz M; Kotler M
Virology; 2004 Dec; 330(1):261-70. PubMed ID: 15527851
[TBL] [Abstract][Full Text] [Related]
8. HIV protease cleaves poly(A)-binding protein.
Alvarez E; Castelló A; Menéndez-Arias L; Carrasco L
Biochem J; 2006 Jun; 396(2):219-26. PubMed ID: 16594896
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin.
Liu S; Netzel-Arnett S; Birkedal-Hansen H; Leppla SH
Cancer Res; 2000 Nov; 60(21):6061-7. PubMed ID: 11085528
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
12. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
[TBL] [Abstract][Full Text] [Related]
13. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
[TBL] [Abstract][Full Text] [Related]
14. Delivery into cells: lessons learned from plant and bacterial toxins.
Sandvig K; van Deurs B
Gene Ther; 2005 Jun; 12(11):865-72. PubMed ID: 15815697
[TBL] [Abstract][Full Text] [Related]
15. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding.
Li Y; Luo L; Thomas DY; Kang CY
Virology; 2000 Jul; 272(2):417-28. PubMed ID: 10873786
[TBL] [Abstract][Full Text] [Related]
16. Identification of HIV-1 protease cleavage site in human C1-inhibitor.
Gerencer M; Burek V
Virus Res; 2004 Sep; 105(1):97-100. PubMed ID: 15325085
[TBL] [Abstract][Full Text] [Related]
17. Tumor protease-activated, pore-forming toxins from a combinatorial library.
Panchal RG; Cusack E; Cheley S; Bayley H
Nat Biotechnol; 1996 Jul; 14(7):852-6. PubMed ID: 9631009
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the cellular immune response induced by Bacillus thuringiensis Cry1A toxins in mice: effect of the hydrophobic motif from diphtheria toxin.
Guerrero GG; Russell WM; Moreno-Fierros L
Mol Immunol; 2007 Feb; 44(6):1209-17. PubMed ID: 16930715
[TBL] [Abstract][Full Text] [Related]
19. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
[TBL] [Abstract][Full Text] [Related]
20. In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system.
Ohlmann T; Prévôt D; Décimo D; Roux F; Garin J; Morley SJ; Darlix JL
J Mol Biol; 2002 Apr; 318(1):9-20. PubMed ID: 12054764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
